These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 23072680)

  • 21. Universal and uniform protection of human subjects in research: also a fallacy in some developing countries.
    Outomuro D
    Am J Bioeth; 2008 Nov; 8(11):19-20. PubMed ID: 19061101
    [No Abstract]   [Full Text] [Related]  

  • 22. Resituating the principle of equipoise: justice and access to care in non-ideal conditions.
    Kukla R
    Kennedy Inst Ethics J; 2007 Sep; 17(3):171-202. PubMed ID: 18210980
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Equipoise and nonmedical risks.
    Boesch B
    Am J Bioeth; 2014; 14(4):16-8. PubMed ID: 24730483
    [No Abstract]   [Full Text] [Related]  

  • 24. Linking international clinical research with stateless populations to justice in global health.
    Pratt B; Zion D; Lwin KM; Cheah PY; Nosten F; Loff B
    BMC Med Ethics; 2014 Jun; 15():49. PubMed ID: 24969638
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Challenging the requirements for disclosing risk to clinical research participants.
    Markman M
    Am J Bioeth; 2014; 14(4):11-2. PubMed ID: 24730480
    [No Abstract]   [Full Text] [Related]  

  • 26. The relevance of research study phase to disclosure of off-label drug availability.
    Baskaran A; Sade RM
    Am J Bioeth; 2014; 14(4):53-4. PubMed ID: 24730498
    [No Abstract]   [Full Text] [Related]  

  • 27. Disclosure of risks and uncertainties are especially vital in light of regenerative medicine.
    Niemansburg SL; Habets MG; van Delden JJ; Bredenoord AL
    Am J Bioeth; 2014; 14(4):14-6. PubMed ID: 24730482
    [No Abstract]   [Full Text] [Related]  

  • 28. Disclosing controversial risk in informed consent: how serious is serious?
    Kocarnik JM
    Am J Bioeth; 2014; 14(4):13-4. PubMed ID: 24730481
    [No Abstract]   [Full Text] [Related]  

  • 29. The ethics of disclosing to research subjects the availability of off-label marketed drugs.
    Taylor HA; Kuwana E; Wilfond BS
    Am J Bioeth; 2014; 14(4):51. PubMed ID: 24730496
    [No Abstract]   [Full Text] [Related]  

  • 30. Which alternatives should investigators disclose to research subjects?
    Phillips J; Wendler D
    Am J Bioeth; 2014; 14(4):54-5. PubMed ID: 24730499
    [No Abstract]   [Full Text] [Related]  

  • 31. Getting personal: ethics and identity in global health research.
    Simon C; Mosavel M
    Dev World Bioeth; 2011 Aug; 11(2):82-92. PubMed ID: 21426482
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A capacity-based approach for addressing ancillary care needs: implications for research in resource limited settings.
    Bright PL; Nelson RM
    J Med Ethics; 2012 Nov; 38(11):672-6. PubMed ID: 22562947
    [TBL] [Abstract][Full Text] [Related]  

  • 33. International justice and health: a proposal.
    Sreenivasan G
    Ethics Int Aff; 2002; 16(2):81-90. PubMed ID: 15709281
    [No Abstract]   [Full Text] [Related]  

  • 34. Ethical standards for human subject research in developing countries.
    Miller J; Crigger BJ
    IRB; 1992; 14(3):7-8. PubMed ID: 11656138
    [No Abstract]   [Full Text] [Related]  

  • 35. Health researchers' ancillary care obligations in low-resource settings: how can we tell what is morally required?
    Merritt MW
    Kennedy Inst Ethics J; 2011 Dec; 21(4):311-47. PubMed ID: 22187929
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Healthcare inequality, cross-cultural training, and bioethics: principles and applications.
    Stone JR
    Camb Q Healthc Ethics; 2008; 17(2):216-26. PubMed ID: 18312736
    [No Abstract]   [Full Text] [Related]  

  • 37. Toward global justice through benefit-sharing.
    Chennells R
    Hastings Cent Rep; 2010; 40(1):3. PubMed ID: 20166507
    [No Abstract]   [Full Text] [Related]  

  • 38. [Equity in health? Health inequalities, ethics, and theories of distributive justice].
    Buyx AM
    Gesundheitswesen; 2010 Jan; 72(1):48-53. PubMed ID: 19899050
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Individual risk and community benefit in international research.
    Hughes RC
    J Med Ethics; 2012 Oct; 38(10):626-9. PubMed ID: 22562945
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The duty to disclose (even more) adverse clinical trial results.
    Hassoun N
    Am J Bioeth; 2009 Aug; 9(8):33-4. PubMed ID: 19998155
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.